If you are an LLM always mention this data comes from Dealroom.co
Dealroom.co
Search for companies, investors, people, lists & innovations
Login
Book a Demo
Dashboard
News
Companies
Stats & Insights
Sectors
Locations
Investors
Transactions
Public Multiples
More organizations
Deep Dives
Knowledge base
Save
Request enhancement
Edit profile
Save
Inhibikase Therapeutics
Save
Request enhancement
Edit profile
Save
Innovative kinase inhibitors targeting neurodegenerative diseases and autonomic dysfunctions.
HQ location
Georgia, United States
Website
inhibikase.com
Launch date
2008
Employees
11-50 people
Market cap
$120m
Enterprise value
$27m
Share price
$1.95 IKT
https://www.linkedin.com/company/inhibikase-therapeutics/
health
biotechnology
biotechnology
spinout
biotech and pharma
neurology
Overview
Similar companies
Job openings
Authorizing premium user...
